Primary Pleural Squamous Cell Carcinoma, Highly Positive PD-L1, Shows Marked Response to Camrelizumab: A Case Report
2021 ◽
Vol 15
◽
pp. 117955492110285
Keyword(s):
Here, we reported the rare case of primary pleural squamous cell carcinoma (PPSCC) in a 71-year-old male patient. After chemo and targeted therapies, the patient showed continuous tumor progression and clinical deterioration. Fortunately, the patient had a high expression level of PD-L1 (80%) in the tumor tissues. Ultimately, the patient survived for additional 6 months with camrelizumab treatment. In summary, camrelizumab may be a good candidate for the treatment of PPSCC, especially in tumors with high PD-L1 expression.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 7
(1)
◽
pp. 33-35
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 6
(7)
◽
pp. 410-412
Keyword(s):